Carcinoembryonic Antigen Market Size, Share, And Growth Report 2032

Carcinoembryonic Antigen Market

Carcinoembryonic Antigen Market by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications), by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5122 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1199.52 Million USD 2150.24 Million 6.7% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Carcinoembryonic Antigen Market, 2016 - 2025, (USD Million)
    • 2.2. Carcinoembryonic Antigen Market: Snapshot
  • Chapter 3. Global Carcinoembryonic Antigen Market - Industry Analysis
    • 3.1. Carcinoembryonic Antigen Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Cancer
      • 3.2.2. Increasing Need for Cost Effective Cancer Diagnosis Tools
    • 3.3. Restraints
      • 3.3.1. Lack of awareness
    • 3.4. Opportunity
      • 3.4.1. Emerging Markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by application segment
      • 3.6.2. Market attractiveness analysis by end user segment
      • 3.6.3. Market attractiveness analysis by regional segment
  • Chapter 4. Global Carcinoembryonic Antigen Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global carcinoembryonic antigen market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New application launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Carcinoembryonic Antigen Market - Application Segment Analysis
    • 5.1. Global carcinoembryonic antigen market overview: by application
      • 5.1.1. Global carcinoembryonic antigen market revenue share, by application, 2018 and 2025
    • 5.2. Gastrointestinal Cancer
      • 5.2.1. Global carcinoembryonic antigen market by Gastrointestinal Cancer, 2016-2025 (USD Million)
    • 5.3. Breast Cancer
      • 5.3.1. Global carcinoembryonic antigen market by Breast Cancer, 2016-2025 (USD Million)
    • 5.4. Lung Cancer
      • 5.4.1. Global carcinoembryonic antigen market by Lung Cancer, 2016-2025 (USD Million)
    • 5.5. Ovarian Cancer
      • 5.5.1. Global carcinoembryonic antigen market by Ovarian Cancer, 2016-2025 (USD Million)
    • 5.6. Prostate Cancer
      • 5.6.1. Global carcinoembryonic antigen market by Prostate Cancer, 2016-2025 (USD Million)
    • 5.7. Thyroid Cancer
      • 5.7.1. Global carcinoembryonic antigen market by Thyroid Cancer, 2016-2025 (USD Million)
    • 5.8. Other Applications
      • 5.8.1. Global carcinoembryonic antigen market by Other Applications, 2016-2025 (USD Million)
  • Chapter 6. Global Carcinoembryonic Antigen Market - End User Segment Analysis
    • 6.1. Global carcinoembryonic antigen market overview: by end user
      • 6.1.1. Global carcinoembryonic antigen market revenue share, by end user, 2018 and 2025
    • 6.2. Hospitals
      • 6.2.1. Global carcinoembryonic antigen market by Hospitals, 2016-2025 (USD Million)
    • 6.3. Research and Academic Institutes
      • 6.3.1. Global carcinoembryonic antigen market by Research and Academic Institutes, 2016-2025 (USD Million)
    • 6.4. Diagnostic Centers
      • 6.4.1. Global carcinoembryonic antigen market by Diagnostic Centers, 2016-2025 (USD Million)
    • 6.5. Other End Users
      • 6.5.1. Global carcinoembryonic antigen market by Other End Users, 2016-2025 (USD Million)
  • Chapter 7. Global Carcinoembryonic Antigen Market - Regional Analysis
    • 7.1. Global carcinoembryonic antigen market overview: by region
      • 7.1.1. Global carcinoembryonic antigen market revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America carcinoembryonic antigen market, by country, 2016-2025 (USD Million)
      • 7.2.2. North America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
      • 7.2.3. North America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.2.4.2. The U.S. carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.2.5.2. Rest of North America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe carcinoembryonic antigen market, by country, 2016-2025 (USD Million)
      • 7.3.2. Europe carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
      • 7.3.3. Europe carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.4. U.K.
        • 7.3.4.1. U.K. carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.3.4.2. U.K. carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.3.5.2. France carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.3.6.2. Germany carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.3.7.2. Rest of Europe carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific carcinoembryonic antigen market, by country, 2016-2025 (USD Million)
      • 7.4.2. Asia Pacific carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
      • 7.4.3. Asia Pacific carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.4.4.2. China carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.4.5.2. Japan carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.4.6.2. India carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America carcinoembryonic antigen market, by country, 2016-2025 (USD Million)
      • 7.5.2. Latin America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
      • 7.5.3. Latin America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.5.4.2. Brazil carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
        • 7.5.5.2. Rest of Latin America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa carcinoembryonic antigen market, 2016-2025 (USD Million)
      • 7.6.2. Middle East & Africa carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
      • 7.6.3. Middle East & Africa carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Boster Biological Technology
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Application Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. RayBiotech, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Application Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Omega Diagnostics Group PLC
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Application Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Creative Diagnostics
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Application Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Correlogic Systems, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Application Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. GenWay Biotech Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Application Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. Quest Diagnostics
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Application Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. F. Hoffmann-La Roche Ltd.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Application Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global carcinoembryonic antigen market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: carcinoembryonic antigen market
5. Global carcinoembryonic antigen market attractiveness, by application
6. Global carcinoembryonic antigen market attractiveness, by end user
7. Global carcinoembryonic antigen market revenue share, by application, 2018 and 2025
8. Global carcinoembryonic antigen market by Gastrointestinal Cancer, 2016-2025 (USD Million)
9. Global carcinoembryonic antigen market by Breast Cancer, 2016-2025 (USD Million)
10. Global carcinoembryonic antigen market by Lung Cancer, 2016-2025 (USD Million)
11. Global carcinoembryonic antigen market by Ovarian Cancer, 2016-2025 (USD Million)
12. Global carcinoembryonic antigen market by Prostate Cancer, 2016-2025 (USD Million)
13. Global carcinoembryonic antigen market by Thyroid Cancer, 2016-2025 (USD Million)
14. Global carcinoembryonic antigen market by Other Applications, 2016-2025 (USD Million)
15. Global carcinoembryonic antigen market revenue share, by end user, 2018 and 2025
16. Global carcinoembryonic antigen market by Hospitals, 2016-2025 (USD Million)
17. Global carcinoembryonic antigen market by Research and Academic Institutes, 2016-2025 (USD Million)
18. Global carcinoembryonic antigen market by Diagnostic Centers, 2016-2025 (USD Million)
19. Global carcinoembryonic antigen market by Other End Users, 2016-2025 (USD Million)
20. Global carcinoembryonic antigen market revenue share, by region, 2018 & 2025
21. North America carcinoembryonic antigen market, 2016-2025 (USD Million)
22. Europe carcinoembryonic antigen market, 2016-2025 (USD Million)
23. Asia Pacific carcinoembryonic antigen market, 2016-2025 (USD Million)
24. Latin America carcinoembryonic antigen market, 2016-2025 (USD Million)
25. Middle East & Africa carcinoembryonic antigen market, 2016-2025 (USD Million)


Table Of Tables

List of Tables

1. Global carcinoembryonic antigen market: snapshot
2. Drivers for carcinoembryonic antigen market: impact analysis
3. Restraints for carcinoembryonic antigen market: impact analysis
4. North America carcinoembryonic antigen market revenue, by country, 2016-2025 (USD Million)
5. North America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
6. North America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
7. The U.S. carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
8. The U.S. carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
9. Rest of North America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
10. Rest of North America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
11. Europe carcinoembryonic antigen market revenue, by country, 2016-2025 (USD Million)
12. Europe carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
13. Europe carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
14. U.K. carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
15. U.K. carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
16. France carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
17. France carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
18. Germany carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
19. Germany carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
20. Rest of Europe carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
21. Rest of Europe carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
22. Asia Pacific carcinoembryonic antigen market revenue, by country, 2016-2025 (USD Million)
23. Asia Pacific carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
24. Asia Pacific carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
25. China carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
26. China carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
27. Japan carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
28. Japan carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
29. India carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
30. India carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
31. Rest of Asia Pacific carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
32. Rest of Asia Pacific carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
33. Latin America carcinoembryonic antigen market revenue, by country, 2016-2025 (USD Million)
34. Latin America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
35. Latin America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
36. Brazil carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
37. Brazil carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
38. Rest of Latin America carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
39. Rest of Latin America carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)
40. Middle  East & Africa carcinoembryonic antigen market revenue, by application, 2016-2025 (USD Million)
41. Middle  East & Africa carcinoembryonic antigen market revenue, by end user, 2016-2025 (USD Million)

Methodology

FrequentlyAsked Questions

Carcinoembryonic antigens (CEA) are class of proteins usually seen in very low amounts in the blood of adults. In various types of cancers as well as benign non-cancerous conditions, the levels of carcinoembryonic antigen in the blood may be increased.

According to study, the Carcinoembryonic Antigen Market size was worth around USD 1199.52million in 2023 and is predicted to grow to around USD 2150.24 million by 2032.

The CAGR value of Carcinoembryonic Antigen Market is expected to be around 6.7% during 2024-2032.

North America has been leading the Carcinoembryonic Antigen Market and is anticipated to continue on the dominant position in the years to come.

The Carcinoembryonic Antigen Market is led by players like Boster Biological Technology, RayBiotech, Inc., Omega Diagnostics Group PLC, Creative Diagnostics, Correlogic Systems, Inc., GenWay Biotech Inc., Quest Diagnostics, and F. Hoffmann-La Roche Ltd. among others.

  • zion payment modes

List of Contents

SizeOverviewSegmentationReport ScopeRegional AnalysisCompetitive PlayersThe Global Market is segmented as follows:

HappyClients